Reported Earnings • May 31
Full year 2026 earnings released: ₹0.22 loss per share (vs ₹0.34 profit in FY 2025) Full year 2026 results: ₹0.22 loss per share (down from ₹0.34 profit in FY 2025). Revenue: ₹75.2m (down 22% from FY 2025). Net loss: ₹1.72m (down 178% from profit in FY 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance. Ankündigung • May 22
Lime Chemicals Limited to Report Q4, 2026 Results on May 30, 2026 Lime Chemicals Limited announced that they will report Q4, 2026 results at 3:30 PM, Indian Standard Time on May 30, 2026 Reported Earnings • Feb 16
Third quarter 2026 earnings released: ₹0.14 loss per share (vs ₹0.09 profit in 3Q 2025) Third quarter 2026 results: ₹0.14 loss per share (down from ₹0.09 profit in 3Q 2025). Revenue: ₹15.7m (down 40% from 3Q 2025). Net loss: ₹797.0k (down 226% from profit in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance. Ankündigung • Feb 03
Lime Chemicals Limited to Report Q3, 2026 Results on Feb 14, 2026 Lime Chemicals Limited announced that they will report Q3, 2026 results at 3:30 PM, Indian Standard Time on Feb 14, 2026 Reported Earnings • Nov 16
Second quarter 2026 earnings released: ₹0.25 loss per share (vs ₹0.11 loss in 2Q 2025) Second quarter 2026 results: ₹0.25 loss per share (further deteriorated from ₹0.11 loss in 2Q 2025). Revenue: ₹14.9m (down 38% from 2Q 2025). Net loss: ₹1.59m (loss widened 195% from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Ankündigung • Nov 08
Lime Chemicals Limited to Report Q2, 2026 Results on Nov 14, 2025 Lime Chemicals Limited announced that they will report Q2, 2026 results on Nov 14, 2025 Ankündigung • Sep 08
Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025 Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025. New Risk • Aug 15
New major risk - Revenue size The company makes less than US$1m in revenue. Total revenue: ₹87m (US$989k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Revenue is less than US$1m (₹87m revenue, or US$989k). Market cap is less than US$10m (₹95.0m market cap, or US$1.09m). Valuation Update With 7 Day Price Move • Aug 14
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹14.60, the stock trades at a trailing P/E ratio of 42.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 38% over the past three years. New Risk • Jul 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$10m (₹99.9m market cap, or US$1.16m). Minor Risk Revenue is less than US$5m (₹97m revenue, or US$1.1m). Reported Earnings • Jun 02
Full year 2025 earnings released: EPS: ₹0.31 (vs ₹0.76 loss in FY 2024) Full year 2025 results: EPS: ₹0.31 (up from ₹0.76 loss in FY 2024). Revenue: ₹102.8m (down 1.7% from FY 2024). Net income: ₹2.21m (up ₹7.13m from FY 2024). Profit margin: 2.2% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. Ankündigung • May 17
Lime Chemicals Limited to Report Q4, 2025 Results on May 30, 2025 Lime Chemicals Limited announced that they will report Q4, 2025 results on May 30, 2025 New Risk • Apr 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.4% operating cash flow to total debt). Market cap is less than US$10m (₹106.0m market cap, or US$1.24m). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Revenue is less than US$5m (₹104m revenue, or US$1.2m). Buy Or Sell Opportunity • Feb 17
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 28% to ₹20.00. The fair value is estimated to be ₹25.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Feb 15
Third quarter 2025 earnings released: EPS: ₹0.09 (vs ₹0.11 loss in 3Q 2024) Third quarter 2025 results: EPS: ₹0.09 (up from ₹0.11 loss in 3Q 2024). Revenue: ₹26.5m (up 2.0% from 3Q 2024). Net income: ₹635.0k (up ₹1.28m from 3Q 2024). Profit margin: 2.4% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance. Ankündigung • Feb 03
Lime Chemicals Limited to Report Q3, 2025 Results on Feb 14, 2025 Lime Chemicals Limited announced that they will report Q3, 2025 results on Feb 14, 2025 Buy Or Sell Opportunity • Nov 25
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 3.1% to ₹25.55. The fair value is estimated to be ₹32.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last 3 years. Meanwhile, the company became loss making. New Risk • Nov 23
New major risk - Revenue and earnings growth Earnings have declined by 4.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.4% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 4.5% per year over the past 5 years. Market cap is less than US$10m (₹174.9m market cap, or US$2.07m). Minor Risk Revenue is less than US$5m (₹104m revenue, or US$1.2m). Ankündigung • Nov 02
Lime Chemicals Limited to Report Q2, 2025 Results on Nov 14, 2024 Lime Chemicals Limited announced that they will report Q2, 2025 results on Nov 14, 2024 Ankündigung • Aug 30
Lime Chemicals Limited, Annual General Meeting, Sep 30, 2024 Lime Chemicals Limited, Annual General Meeting, Sep 30, 2024. Reported Earnings • Aug 15
First quarter 2025 earnings released: EPS: ₹0.24 (vs ₹0.33 loss in 1Q 2024) First quarter 2025 results: EPS: ₹0.24 (up from ₹0.33 loss in 1Q 2024). Revenue: ₹30.8m (down 5.2% from 1Q 2024). Net income: ₹1.53m (up ₹3.63m from 1Q 2024). Profit margin: 5.0% (up from net loss in 1Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance. Ankündigung • Aug 02
Lime Chemicals Limited to Report Q1, 2025 Results on Aug 14, 2024 Lime Chemicals Limited announced that they will report Q1, 2025 results on Aug 14, 2024 Buy Or Sell Opportunity • Jul 04
Now 15% undervalued The stock has been flat over the last 90 days, currently trading at ₹29.12. The fair value is estimated to be ₹34.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jun 19
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.0% to ₹26.14. The fair value is estimated to be ₹34.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jun 11
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 7.9% to ₹26.26. The fair value is estimated to be ₹33.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Jun 04
Full year 2024 earnings released: ₹0.76 loss per share (vs ₹4.24 profit in FY 2023) Full year 2024 results: ₹0.76 loss per share (down from ₹4.24 profit in FY 2023). Revenue: ₹108.5m (down 30% from FY 2023). Net loss: ₹4.92m (down 118% from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance. Ankündigung • May 20
Lime Chemicals Limited to Report Q4, 2024 Results on May 30, 2024 Lime Chemicals Limited announced that they will report Q4, 2024 results on May 30, 2024 New Risk • Apr 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Market cap is less than US$10m (₹178.2m market cap, or US$2.13m). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Revenue is less than US$5m (₹115m revenue, or US$1.4m). Reported Earnings • Feb 16
Third quarter 2024 earnings released: ₹0.11 loss per share (vs ₹4.38 profit in 3Q 2023) Third quarter 2024 results: ₹0.11 loss per share (down from ₹4.38 profit in 3Q 2023). Revenue: ₹25.9m (down 30% from 3Q 2023). Net loss: ₹645.0k (down 102% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. New Risk • Nov 12
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 88% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (88% accrual ratio). Market cap is less than US$10m (₹172.4m market cap, or US$2.07m). Minor Risk Revenue is less than US$5m (₹126m revenue, or US$1.5m). Reported Earnings • Nov 12
Second quarter 2024 earnings released: ₹0.18 loss per share (vs ₹0.06 loss in 2Q 2023) Second quarter 2024 results: ₹0.18 loss per share (further deteriorated from ₹0.06 loss in 2Q 2023). Revenue: ₹22.9m (down 48% from 2Q 2023). Net loss: ₹1.09m (loss widened 240% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Ankündigung • Nov 04
Lime Chemicals Limited to Report Q2, 2024 Results on Nov 11, 2023 Lime Chemicals Limited announced that they will report Q2, 2024 results at 3:30 PM, Indian Standard Time on Nov 11, 2023 Valuation Update With 7 Day Price Move • Oct 05
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹27.99, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 99% over the past three years. Ankündigung • Sep 07
Lime Chemicals Limited, Annual General Meeting, Sep 30, 2023 Lime Chemicals Limited, Annual General Meeting, Sep 30, 2023, at 11:30 Indian Standard Time. Location: K Star Hotel, Rajiv Gandhi Road, Sector-11, C.B.D. Belapur (East) Navi Mumbai Maharashtra India Agenda: To receive and adopt the Profit and Loss Account for the year ended on 31st March, 2023 and the Balance Sheet as on that date and the reports of Auditors and Directors thereof; to consider directorate reelections; to appoint statutory auditors of the Company and fix their remuneration; to consider Ratification of remuneration of Cost Auditors; and to consider other matters. Reported Earnings • Aug 15
First quarter 2024 earnings released: ₹0.33 loss per share (vs ₹0.12 profit in 1Q 2023) First quarter 2024 results: ₹0.33 loss per share (down from ₹0.12 profit in 1Q 2023). Revenue: ₹33.5m (down 17% from 1Q 2023). Net loss: ₹2.10m (down 361% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has remained flat. Ankündigung • Aug 04
Lime Chemicals Limited to Report Q1, 2024 Results on Aug 14, 2023 Lime Chemicals Limited announced that they will report Q1, 2024 results on Aug 14, 2023 Reported Earnings • Jun 01
Full year 2023 earnings released: EPS: ₹4.24 (vs ₹15.06 in FY 2022) Full year 2023 results: EPS: ₹4.24 (down from ₹15.06 in FY 2022). Revenue: ₹156.0m (up 11% from FY 2022). Net income: ₹27.6m (down 72% from FY 2022). Profit margin: 18% (down from 70% in FY 2022). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹24.06, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 59% over the past three years. Ankündigung • Jan 24
Lime Chemicals Limited to Report Q3, 2023 Results on Feb 14, 2023 Lime Chemicals Limited announced that they will report Q3, 2023 results at 12:15 PM, Indian Standard Time on Feb 14, 2023 Ankündigung • Sep 30
Lime Chemicals Limited Appoints Pramod N. Manjrekar as Non-Executive Independent Director 52nd Annual General Meeting of Lime Chemicals Limited held on 30" September 2022. announced Appointment of Mr. Pramod N. Manjrekar, as non-executive Independent Director. Reported Earnings • Sep 10
Full year 2022 earnings released: EPS: ₹15.06 (vs ₹0.21 in FY 2021) Full year 2022 results: EPS: ₹15.06 (up from ₹0.21 in FY 2021). Revenue: ₹140.6m (down 37% from FY 2021). Net income: ₹98.0m (up ₹96.6m from FY 2021). Profit margin: 70% (up from 0.6% in FY 2021). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 06
Investor sentiment improved over the past week After last week's 17% share price gain to ₹30.90, the stock trades at a trailing P/E ratio of 2.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 37% over the past three years. Ankündigung • Aug 05
Lime Chemicals Limited to Report Q1, 2023 Results on Aug 13, 2022 Lime Chemicals Limited announced that they will report Q1, 2023 results on Aug 13, 2022 Ankündigung • Jun 03
Lime Chemicals Limited Announces Resignation of Ms. Runel Saxena as Company Secretary/Compliance Officer Lime Chemicals Limited informed that Ms. Runel Saxena, the Company Secretary and Compliance Officer of the Company has resigned from the close of working hours of May 31, 2022. The Company is in the process of appointing new Company Secretary. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improved over the past week After last week's 19% share price gain to ₹32.40, the stock trades at a trailing P/E ratio of 2x. Average trailing P/E is 18x in the Chemicals industry in India. Total loss to shareholders of 6.5% over the past three years. Ankündigung • Feb 02
Lime Chemicals Limited to Report Q3, 2022 Results on Feb 14, 2022 Lime Chemicals Limited announced that they will report Q3, 2022 results on Feb 14, 2022 Valuation Update With 7 Day Price Move • Oct 04
Investor sentiment improved over the past week After last week's 16% share price gain to ₹33.25, the stock trades at a trailing P/E ratio of 2x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 43% over the past three years. Recent Insider Transactions • Aug 23
Non-Executive Non Independent Director recently bought ₹1.6m worth of stock On the 20th of August, Shahnaz Dawoodani bought around 56k shares on-market at roughly ₹27.89 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Aug 18
First quarter 2022 earnings released: EPS ₹16.75 (vs ₹0.71 in 1Q 2021) First quarter 2022 results: Revenue: ₹24.2m (down 57% from 1Q 2021). Net income: ₹109.0m (up ₹104.4m from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings. Reported Earnings • Jul 06
Full year 2021 earnings released: EPS ₹0.21 (vs ₹0.49 loss in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹246.2m (down 22% from FY 2020). Net income: ₹1.35m (up ₹4.53m from FY 2020). Profit margin: 0.5% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • May 28
Investor sentiment improved over the past week After last week's 18% share price gain to ₹25.85, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 74% over the past three years. Reported Earnings • Feb 14
Third quarter 2021 earnings released: ₹0.04 loss per share (vs ₹0.063 loss in 3Q 2020) The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₹53.6m (down 27% from 3Q 2020). Net loss: ₹244.0k (loss narrowed 41% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 34% per year, which means it has not declined as severely as earnings. Ankündigung • Feb 06
Lime Chemicals Limited to Report Q3, 2021 Results on Feb 13, 2021 Lime Chemicals Limited announced that they will report Q3, 2021 results on Feb 13, 2021 Is New 90 Day High Low • Jan 05
New 90-day high: ₹23.55 The company is up 67% from its price of ₹14.10 on 07 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment improved over the past week After last week's 15% share price gain to ₹18.20, the stock is trading at a trailing P/E ratio of 8.2x, up from the previous P/E ratio of 7.1x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 64%. Ankündigung • Dec 20
Lime Chemicals Limited Announces Resignation of Suresh John as 'Non-Executive Independent Director Designated as Chairman of the Board of Directors of the Company with Effect from 19Th December 2020 Lime Chemicals Limited announced that Mr. Suresh John has resigned from 'Non-Executive Independent Director designated as Chairman of the Board of Directors of the Company with effect from 19th December 2020. Is New 90 Day High Low • Oct 23
New 90-day high: ₹23.35 The company is up 4.0% from its price of ₹22.50 on 24 July 2020. The Indian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. 
